Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden

Abstract

Patients with a higher CCI are at an increased risk of developing HK and appear more prone to adverse clinical outcomes associated with abnormal serum K+ levels, warranting additional routine clinical monitoring.